Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms.
暂无分享,去创建一个
A. Daley | Y. Qu | D. Rouch | M. Deighton | T. Istivan | Yue Qu | Taghrid S Istivan | Andrew J Daley | Duncan A Rouch | Margaret A Deighton
[1] M. Allon. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] K. Ko,et al. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. , 2006, The Journal of antimicrobial chemotherapy.
[3] I. Raad,et al. Optimal Antimicrobial Catheter Lock Solution, Using Different Combinations of Minocycline, EDTA, and 25-Percent Ethanol, Rapidly Eradicates Organisms Embedded in Biofilm , 2006, Antimicrobial Agents and Chemotherapy.
[4] H. Ceri,et al. The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms , 1999, Journal of Clinical Microbiology.
[5] D. Qu,et al. Formation and properties of in vitro biofilms of ica-negative Staphylococcus epidermidis clinical isolates. , 2007, Journal of medical microbiology.
[6] W. Poole,et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.
[7] D. K. Benjamin,et al. Bacteremia, central catheters, and neonates: when to pull the line. , 2001, Pediatrics.
[8] S. Percival,et al. Use of In Vivo-Generated Biofilms from Hemodialysis Catheters To Test the Efficacy of a Novel Antimicrobial Catheter Lock for Biofilm Eradication In Vitro , 2004, Journal of Clinical Microbiology.
[9] I. Chopra,et al. Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus. , 2004, The Journal of antimicrobial chemotherapy.
[10] W. Dunne,et al. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm , 1993, Antimicrobial Agents and Chemotherapy.
[11] S. Patole,et al. Intravenous rifampicin in neonates with persistent staphylococcal bacteraemia , 2002, Acta paediatrica.
[12] M. Edmond,et al. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. , 2007, JPEN. Journal of parenteral and enteral nutrition.
[13] J. Cheesbrough,et al. Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis. , 2002, The Journal of antimicrobial chemotherapy.
[14] R. Donlan. Role of Biofilms in Antimicrobial Resistance , 2000, ASAIO journal.
[15] R. Soutar,et al. Complications of the ethanol-lock technique in the treatment of central venous catheter sepsis. , 2005, The Journal of infection.
[16] F. K. Gould,et al. Use of antibiotic locks to treat colonized central venous catheters. , 2001, The Journal of antimicrobial chemotherapy.
[17] K. Lewis. Persister cells and the riddle of biofilm survival , 2005, Biochemistry (Moscow).
[18] M. Deighton,et al. Methods for studying biofilms produced by Staphylococcus epidermidis. , 2001, Methods in enzymology.
[19] C. Edmiston,et al. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. , 2006, American journal of surgery.
[20] Frederik Hammes,et al. Assessment and Interpretation of Bacterial Viability by Using the LIVE/DEAD BacLight Kit in Combination with Flow Cytometry , 2007, Applied and Environmental Microbiology.
[21] S. Aaron,et al. Multiple Combination Bactericidal Testing of Staphylococcal Biofilms from Implant-Associated Infections , 2006, Antimicrobial Agents and Chemotherapy.
[22] L. Baddour,et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices , 1985, Journal of clinical microbiology.
[23] E. Castagnola,et al. Catheter Lock and Systemic Infusion of Linezolid for Treatment of Persistent Broviac Catheter-Related Staphylococcal Bacteremia , 2006, Antimicrobial Agents and Chemotherapy.
[24] B. Almirante,et al. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. , 2006, The Journal of antimicrobial chemotherapy.
[25] A. Rønnestad,et al. Coagulase-Negative Staphylococcal Sepsis in Neonates: Association Between Antibiotic Resistance, Biofilm Formation and the Host Inflammatory Response , 2005, The Pediatric infectious disease journal.
[26] L. Wong,et al. Inhibition by ethanol of the growth of biofilm and dispersed microcosm dental plaques. , 1996, Archives of oral biology.
[27] S. Chambers,et al. Use of ethanol locks to prevent recurrent central line sepsis. , 2004, The Journal of infection.
[28] J. Minton,et al. Insufficient penetration of systemic vancomycin into the PermCath lumen. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[29] B. Souweine,et al. Ethanol lock solution as an adjunct treatment for preventing recurrent catheter-related sepsis--first case report in dialysis setting. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] A. Widmer,et al. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. , 1994, The Journal of antimicrobial chemotherapy.
[31] É. Lerebours,et al. Efficacy of antibiotic-lock technique with teicoplanin in staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. , 2002, JPEN. Journal of parenteral and enteral nutrition.
[32] W. Onland,et al. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. , 2006, Archives of pediatrics & adolescent medicine.
[33] B. Messing,et al. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. , 1988, JPEN. Journal of parenteral and enteral nutrition.
[34] I. Raad,et al. Comparative In Vitro Efficacies of Various Catheter Lock Solutions , 2006, Antimicrobial Agents and Chemotherapy.
[35] J. Rotschafer,et al. Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads , 1993, Antimicrobial Agents and Chemotherapy.
[36] D. Grando,et al. Coagulase-negative staphylococci in very-low-birth-weight infants: inability of genetic markers to distinguish invasive strains from blood culture contaminants , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[37] S. Stocks. Mechanism and use of the commercially available viability stain, BacLight , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[38] G. Peters,et al. Pathogenesis of infections due to coagulase-negative staphylococci. , 2002, The Lancet. Infectious diseases.
[39] G. Pugliese,et al. Biofilms and Planktonic Cells of Pseudomonas aeruginosa Have Similar Resistance to Killing by Antimicrobials , 2002, Infection Control & Hospital Epidemiology.
[40] Jerome J. Schentag,et al. Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar , 1994, Antimicrobial Agents and Chemotherapy.
[41] H. Caron,et al. Prophylactic antibiotics for preventing early Gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review. , 2005, Cancer treatment reviews.
[42] R. Colwell,et al. Viable but nonculturable Vibrio cholerae O1 in biofilms in the aquatic environment and their role in cholera transmission , 2007, Proceedings of the National Academy of Sciences.
[43] P. Villari,et al. Molecular Epidemiology of Staphylococcus epidermidis in a Neonatal Intensive Care Unit over a Three-Year Period , 2000, Journal of Clinical Microbiology.
[44] M. Allon. Dialysis catheter-related bacteremia: treatment and prophylaxis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[45] J. V. van Woensel,et al. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. , 2007, The Cochrane database of systematic reviews.
[46] J. Costerton,et al. Antimicrobial Activity of a Novel Catheter Lock Solution , 2002, Antimicrobial Agents and Chemotherapy.
[47] L. Mermel,et al. Guidelines for the management of intravascular catheter-related infections. , 2001, Infection control and hospital epidemiology.
[48] M. Cormican,et al. Linezolid Compared with Eperezolid, Vancomycin, and Gentamicin in an In Vitro Model of Antimicrobial Lock Therapy for Staphylococcus epidermidis Central Venous Catheter-Related Biofilm Infections , 2003, Antimicrobial Agents and Chemotherapy.
[49] J. Leiva,et al. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. , 2001, The Journal of antimicrobial chemotherapy.
[50] Hualiang Jiang,et al. Antimicrobial activities of YycG histidine kinase inhibitors against Staphylococcus epidermidis biofilms. , 2007, FEMS microbiology letters.